Innovation Pharmaceuticals Inc (IPIX): There were problems with Kepivance (Pali...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Monday, 08/07/2017 9:05:20 PM

Monday, August 07, 2017 9:05:20 PM

There were problems with Kepivance (Palifermin) that restricted its use for oral mucositis.

Read on:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75669686

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM

Only $200 per official company press release!